Table 3. Effects of the copper (II) complex on liver function in AOM-induced colon cancer.
Groups | Total protein (g/L) | Albumin (g/L) | AST (IU/L) | ALT (IU/L) | GGT(IU/L) |
Negative control group | 67.32±0.34 | 12.27±0.54 | 207.2±2.53 | 63±2.38 | 5.5±0.3 |
Cancer control group | 69.5±0.39 | 9.0±0.31 | 229.6±7.2 | 69.5±0.68 | 3.7±0.6 |
Positive control group | 73.6±2.1 | 11.3±0.89 | 182.0±4.5 | 50.0±0.92 | 6.1±0.48 |
Cu(BrHAP)2 (2.5 mg/kg) | 68.5±0.67 | 10.5±0.4 | 209.5±6.1 | 64.2±0.63 | 4.1±0.1 |
Cu(BrHAP)2 (5 mg/kg) | 70.9±1.1 | 11.3±0.42 | 212.0±10.6 | 62.0±3.4 | 4.3±0.32 |
The values are expressed as the mean ± the SEM There were no significant differences between groups. The significance value was set at P < 0.05 compared to the cancer control group. TB: total bilirubin; ALT: alanine aminotransferase; AST: aspartate aminotransferase; GGT: g-glutamyl transferase.